stock offering Oncocyte Inks At-Market Agreement to Sell Up to $50M in Stock The company said any proceeds raised will help continue commercialization of its lead test, DetermaRx, and fund the development of the rest of its pipeline. Singular Genomics Systems Raises $258M in Upsized IPO The San Diego-based sequencing technology firm added nearly 2 million shares on the eve of its IPO, and its shares rose 17 percent on the first day of trading. SomaLogic to Go Public Through Merger With Special Purpose Acquisition Company Following the transaction, which values the company at roughly $1.2 billion and will provide cash proceeds of around $650 million, SomaLogic will list on the Nasdaq. Olink Prices $264M Initial Public Offering The company is offering 17,647,058 common shares at $20 per share that are expected to begin trading on the Nasdaq Global Market on March 25. Investor Interest in Proteomics Rising on New, Improving Technologies Premium Investor appetite for proteomics is growing, driven in part by improvements in mass spec but more significantly by new tech from early-stage firms soon to go public. Feb 11, 2021 Cancer Genetics to Sell $17.5M in Common Stock Through Direct Offering Feb 9, 2021 OpGen Enters $25M Direct Offering Agreement Feb 5, 2021 Oncocyte to Raise $35M in Public Stock Offering Feb 5, 2021 Veracyte Prices $550M Public Offering of Common Stock Feb 4, 2021 Quanterix Prices $250M Public Stock Offering Jan 28, 2021 Seer Prices $110.5M Follow-on Stock Offering Jan 27, 2021 Personalis Prices $150M Public Stock Offering Jan 26, 2021 Seer Plans Offering of 3.5M Shares of Common Stock Jan 22, 2021 Predictive Oncology Announces $4.1M Direct Offering Jan 22, 2021 Invitae Prices $400M Common Stock Offering Jan 21, 2021 Genetic Technologies to Raise $6.6M in Direct Offering Jan 21, 2021 CareDx Prices $175M Common Stock Offering Jan 20, 2021 Oncocyte to Raise $25M in Stock Sale to Institutional Investors Jan 20, 2021 Invitae to Raise $400M in Proposed Public Offering Jan 20, 2021 Bionano Genomics to Raise $200M in Public Stock Offering Jan 19, 2021 Predictive Oncology Prices $2.2M Direct Offering Jan 8, 2021 Bionano Genomics Expects Up to 50 Percent Q4 Revenue Growth, Prices $88.5M Public Stock Offering Jan 7, 2021 NeoGenomics Prices $500M Offering of Stock, Senior Notes Jan 7, 2021 DermTech Prices $125M Public Offering of Common Stock Dec 16, 2020 Castle Biosciences Prices $232M Public Offering of Common Stock Load More Breaking News Quest Diagnostics to Offer Biocept's Target Selector NGS Lung Cancer Test Novacyt 2020 Revenues Surge on Strong Demand for SARS-CoV-2 Testing Products Leidos Wins CDC Bioinformatics Contract Worth up to $13M Thermo Fisher Scientific Next-Generation SARS-CoV-2 PCR Test Nabs CE-IVD Mark Cytosine Base Editor Enables Genome-Wide Genetic Function Screening G42 Healthcare, Seegene to Offer Mobile Molecular Diagnostic Labs in Middle East, North Africa The Scan Renewed Gain-of-Function Worries The New York Times writes that the pandemic is renewing concerns about gain-of-function research. Who's Getting the Patents? A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports. Other Uses CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2. PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.